Zobrazeno 1 - 10
of 638
pro vyhledávání: '"ospemifene"'
Publikováno v:
International Journal of Women's Health, Vol Volume 16, Pp 1049-1053 (2024)
Giulia Marchetti,1 Annika Taithongchai,2 Dudley Robinson2 1Urogynaecology Department, Irmandade de Misericórdia da Santa Casa de São Paulo, Sao Paulo, Brazil; 2Urogynaecology Department, King’s College Hospital, London, UKCorrespondence: Dudley R
Externí odkaz:
https://doaj.org/article/0686f4150af043a9b134428746dde4c5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Медицинский совет, Vol 0, Iss 13, Pp 91-96 (2020)
At the onset of menopause, the urogenital symptoms begin to develop simultaneously with vasomotor symptoms: vaginal soreness, itching and dryness, dyspareunia, etc. The development of atrophic changes in the urogenital tract greatly reduces the quali
Externí odkaz:
https://doaj.org/article/0f384bbd4f3d46c79e9a768b342966d4
Publikováno v:
Drugs in Context, Vol 9, Pp 1-6 (2020)
The pathophysiological changes associated with hypoestrogenism of menopause, a condition known as genitourinary syndrome of menopause, are responsible for the hallmark symptoms of vulvovaginal atrophy (VVA), namely dyspareunia secondary to vaginal dr
Externí odkaz:
https://doaj.org/article/0b41a62e9b81404bb165053516ef9715
Publikováno v:
Drugs in Context, Vol 9, Pp 1-5 (2020)
Vaginal laser therapy is a non-hormonal treatment option for vulvovaginal atrophy (VVA), a component of the genitourinary syndrome of menopause. Through a microablative and/ or thermal effect on atrophic vaginal epithelium, laser therapy activates gr
Externí odkaz:
https://doaj.org/article/bf0b45da492d4c8fbb46dd5417591aab
Autor:
María del Carmen Pingarrón Santofimia, Silvia Pilar González Rodríguez, Mariella Lilue, Santiago Palacios
Publikováno v:
Drugs in Context, Vol 9, Pp 1-10 (2020)
Selective estrogen receptor modulators (SERMs) exhibit varying agonist/antagonist activities on estrogen receptors in tissues, although most SERMs, including ospemifene, have agonist effects on bone. In this article, outcomes in relation to bone home
Externí odkaz:
https://doaj.org/article/e5130506186d4ca0a3d772cb266ad65b
Publikováno v:
Drugs in Context, Vol 9, Pp 1-4 (2020)
The changes that occur in sex hormone levels, body composition, and lipid/lipoprotein levels during the menopause transition, together with vascular remodeling, increase the risk of cardiovascular disease (CVD) in postmenopausal women. Any treatments
Externí odkaz:
https://doaj.org/article/5354a588e5f54c0f8829ff66885ce77b
Autor:
Santiago Palacios
Publikováno v:
Drugs in Context, Vol 9, Pp 1-5 (2020)
The menopause-related decline in estrogen levels leads to an array of genital, sexual, and urinary symptoms collectively known as genitourinary syndrome of menopause. The constellation of symptoms associated with vulvar and vaginal atrophy (VVA) can
Externí odkaz:
https://doaj.org/article/0001c8ae35bb4c7b9e3e4d64a3d473d2
Publikováno v:
Drugs in Context, Vol 9, Pp 1-6 (2020)
Pelvic floor muscle atrophy and collagen loss in connective tissue due to declining estrogen production in women as they age may underlie the increasing prevalence of urge and stress incontinence. Estrogen therapy can correct the deficiency of estrog
Externí odkaz:
https://doaj.org/article/9ba27793bda64233b5f8f967107842c5